News

INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with early ...
For patients with mild cognitive impairment (MCI) associated with Alzheimer disease (AD), those in the highest tertile of the ...
Researchers have found in a new retrospective cohort study that vitamin D supplementation led to significant improvements in ...
The study enrolled 208 patients with mild Alzheimer's disease (AD), or mild cognitive impairment, an early sign of the disease, who were randomly chosen to receive a weekly subcutaneous injection of ...
In the Phase 2 MINDFuL trial of XProTM in patients with early Alzheimer's Disease (AD) with biomarkers of inflammation, the modified intent-to-treat ...
It wasn’t that long ago when screaming “follow the science” was all the rage, even if the alleged science wasn’t remotely ...
Is it just age-related forgetfulness, or an early sign of something more serious? Neurologists outline the subtle differences ...
INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it has closed its registered direct offering, announced on June 27, 2025, ...
Alzheimer’s Pipeline Report, released by the Kirk Kerkorian School of Medicine at UNLV, reveals dozens of promising drug trials that could bring hope to millions of families. The research ...
Santa Clarita-based Tombot Inc. nabbed $6.1 million in series A funding, the health robotics company announced in June. Tombot is best known for Jennie, a ...
This summer, we have launched Dementia Unseen a bold new campaign demanding that the UK Government guarantees the right to an ...
I remember the first time I was on stage and scrambled my words. If my lines in a play were supposed to be "Sherwin-Williams, ...